News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE
Amgen's Repatha receives positive CHMP opinion to expand use for cardiovascular disease risk reduction in high-risk adults without prior heart attack or stroke, based on VESALIUS-CV trial results -
COMMUNIQUÉ DE PRESSE
Worksport Announces Q2 2026 Earnings Call and Investor Town Hall for August 11, 2026; CEO Believes Current Market Valuation Does Not Yet Fully Reflect Recent Positive Operating Progress
Worksport to host Q2 2026 earnings call on August 11, 2026, at 4:30 p.m. ET, followed by investor townhall with CEO. Worksport announces strong Q2 performance and progress